Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
targeting Akt1
and matrix metalloproteinase activities of CRC cell lines
Highly stabilized amorphous 3-bis(4-methoxyphenyl)methylene-2-indolinone (TAS-301) in melt-adsorbed products with silicate compounds
Bisquinolines
Gilteritinib - CAS# 1254053-43-4 Catalog No.:M8549-10 targeting Akt1Gilteritinib, also known as ASP2215, is a potent FLT3 AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3 ITD and FLT3 D835 mutations. In invitro, among the 78 tyrosine kinases tested, ASP2215 inhibited FLT3, LTK, ALK, and AXL kinases by over 50% at 1 nM with an IC50 value of 0. 29 nM for FLT3, approximately 800 fold more potent than for c KIT, the inhibition of which is linked to a potential risk of
US$ 17.89
US$ 122.40
US$ 21.79
US$ 71.00
US$ 14.89